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Abstract: Phospholipase A1 (PLA1) is an enzyme that hydrolyzes phospholipids and 
produces 2-acyl-lysophospholipids and fatty acids. This lipolytic activity is conserved in a 
wide range of organisms but is carried out by a diverse set of PLA1 enzymes. Where their 
function is known, PLA1s have been shown to act as digestive enzymes, possess central 
roles in membrane maintenance and remodeling, or regulate important cellular mechanisms 
by the production of various lysophospholipid mediators, such as lysophosphatidylserine 
and lysophosphatidic acid, which in turn have multiple biological functions. 
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1. Introduction 
 
Phospholipases form a diverse class of enzymes optimized to hydrolyze phospholipid (PL) 
substrates at specific ester bonds. Phospholipases vary considerably in structure and function, and as 
such they are assembled as a group solely on the basis that they are lipolytic enzymes involved  
in PL metabolism. Two general sets of phospholipases exist, the acyl hydrolases and the 
phosphodiesterases; and the enzymes within each set are classified according to the cleavage of the 
ester bond for which they are specific (Figure 1). Phospholipase A1 (PLA1), phospholipase A2 (PLA2), 
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phospholipase B (PLB), and lysophospholipase A1/2 (LysoPLA1/2) constitute the acyl hydrolases, 
whereas the phosphodiesterases are represented by phospholipase C (PLC) and phospholipase D (PLD). 
Phospholipases exist in almost every type of cell analyzed for their presence and most cells contain 
a multitude of them. For a given PL ester bond, there can be a variety of subtypes of a phospholipase 
that are specific for it that can either exist as secreted, membrane associated, or in cytoplasmic form. 
They may also require cofactors for activity, depending on the isoforms. The functions of 
phospholipases, where known, are as varied as their cellular and tissue localization and properties. 
Nonetheless, three general functions can be ascribed to the physiologic relevance of phospholipases: 
(1) they can serve as digestive enzymes, e.g., PLA are ubiquitous in snake and vespid venoms; (2) they 
can play an important role in membrane maintenance and remodeling, i.e., fatty acid (FA) chains  
of PLs can be cleaved and exchanged by an acyl hydrolase and an acyltransferase, respectively;  
and (3) they can regulate important cellular mechanisms, e.g., creation of bioactive lipid molecules 
used in signal transduction. These three areas of function can be a rather simplistic view accepting 
that, for example, maintaining acyl composition of membranous PLs can be considered quite an 
important regulatory function for the cell, even though the reason that cellular membranes require a 
heterogeneous mixture of PL fatty acids is still not fully understood [1]. These three themes will be 
explored in more detail in subsequent sections. 
Among the different sorts of phospholipases, the most studied and well understood are PLA2, PLC, 
and PLD, all of which play proven important roles in the creation of bioactive lipid molecules. 
Although this review will focus on PLA1, a brief overview of the other phospholipases and their 
biological significance will also be given to gain perspective. 
Figure 1. Ester Bond Specificity of the Phospholipases. PLA1, PLA2, and PLC catalyze the 
hydrolysis of the ester bond emanating from the sn-1(1), sn-2 (2), and sn-3 (3) carbon, 
respectively. PLD hydrolyzes the other phosphodiester bond. PLB cleaves both the sn-1 
and sn-2 ester bonds. * = LysoPLA can either be specific for the sn-1 or sn-2 bond, or both, 
when one or the other acyl chain is missing. R1 and R2, (CH2)nCH3; R3, various headgroups. 
 
1.1. Phospholipase A1  
 
PLA1 (EC 3.1.1.32) catalyzes the hydrolysis of FAs exclusively at the sn-1 position of PLs. A free 
fatty acid (FFA) and a lysophospholipid (lysoPL) are the products of a PLA1 reaction (Figure 2). This 
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class of phospholipase is not well understood, and no crystal structures exist for any true PLA1 [2,3]. 
The assignment of a function for any PLA1 from any organism has yet to be firmly established. 
Historically, the biological role of this acyl hydrolase was often defined by its anticipated participation 
in the Lands Cycle, which is a deacylation-reacylation cycle that PLs are suspected to undergo in order 
to remodel their acyl chains to preserve a homeostatic molecular species composition of PLs in 
membrane bi-layers [4]. However, only one PLA1 has ever been directly implicated in a Lands  
Cycle [5], though this cycle has repeatedly been shown to occur at the sn-2 position via the action of 
PLA2, and studies continue to observe the phenomenon [6–10]. The assignment of a similar function 
for PLA1, though potentially valid, cannot be decuded based on experimental data. Understanding of 
these enzymes is limited, though some progress has been made over the past 20 years [11]. 
What is intriguing is the observation that despite a theoretical role in the Lands Cycle, none of the 
PLA1 cloned and characterized have been linked to membrane turnover and remodeling roles. On the 
contrary, there is some evidence to suggest that some PLA1 enzymes are virulence factors [12] or act to 
generate bioactive lysoPL molecules. For example, lysoPL mediators such as lysophosphatidic  
acid (lysoPA) [13] are second messenger signaling components in pathways that vary in complexity 
and evolutionary conservation, and they have been implicated in numerous processes such as 
proliferation, protein transport, differentiation, invasion, and morphogenesis [14]. By activating 
specific G-protein coupled lysoPL receptors, they are now viewed as key factors in cell-to-cell 
communication [15]. The synthesis and regulation of the formation of lysoPLs are not fully 
understood, a reason why PLA1 is an important enzyme to study as it could be involved in their formation. 
The FA product from a PLA1 reaction also has bioactive potential. This has been shown in plants, 
where a PLA1 regulates jasmonic acid biosynthesis. Also, it has been postulated for decades that sn-2 
arachidonic acid (AA) cleavage from PLs may sometimes be mediated by concerted sequential 
PLA1/LysoPLA2 activities [16–24]. No cloned PLA1 has been implicated in this alternative route, and 
therefore it remains circumstantial with regards to the in vitro studies, which provide the most indirect 
evidence [16,22,23]. 
 
1.2. The Other Acyl Hydrolases: Phospholipase A2, B, and Lysophospholipase 
 
PLA2 (EC 3.1.1.4) mediates acyl ester hydrolysis at the sn-2 position of PLs. PLA2 are quite well 
conserved across taxa, and they consist of a broad range of enzymes that segregate into one of eleven 
groups within the superfamily [25]. Numerous PLA2 can contribute to lysoPL signaling events [26] 
and can even down-regulate the bioactive lysoPL platelet activating factor (PAF) with the sn-2  
acetate-specific cleavage of PAF by PAF acetyl hydrolase (PAF-AH) [27]. However, PLA2 is most 
noted for its role in initiating the AA cascade (Figure 2) [28]. The sn-2 reacylation step of the Lands 
Cycle appears to be quite specific for AA in a number of cells [29]. Once liberated by a cytoplasmic 
PLA2, AA is converted into over 150 known eicosanoids, including prostaglandins, leukotrienes, and 
thromboxanes, all powerful local hormones that act as mediators in many important processes such as 
inflammation in the higher eukaryotes [30]. Numerous crystal structures exist in this class of enzymes 
whose active mechanism either utilizes a catalytic histidine in a so-called dyad or a catalytic serine in 
either a dyad or a triad [25,27,31]. 
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Figure 2. Regulatory Processes Linked to PL Metabolism. The phospholipases known to 
produce bioactive lipid molecules are shown in blue, and their second messenger 
metabolites, or their signal-transduced responses, are boxed. Other enzymes utilized in PL 
and FA metabolism are in red. DAG, diacylglycerol; IP3, inositol(1,4,5)phosphate; PKC, 
protein kinase C; AA, arachidonic acid; LO, lipoxygenase; COX 1,2, cyclooxygenase 1 
and 2; PG, prostaglandin; FFA, free fatty acid; CoA, coenzyme A; PLC, phospholipase C; 
cPLA2, cytoplasmic phospholipase A2, PLD, phospholipase D; PA-PLA1, phosphatidic 
acid phospholipase A1; PLA1, phospholipase A1, LysoPLA1, lysophospholipase A;  
ACS, acyl-CoA synthetase; PA, glycerophosphatidic acid; PC, phosphatidylcholine; PI, 
phosphatidylinositol. * = theoretical pathway based on indirect in vitro evidence. 
 
 
PLB is able to hydrolyze both the sn-1 and sn-2 FAs of PLs (Figure 1). Glycosylation is a  
common feature of PLBs, such as the one from Penicillium notatum, which contains numerous  
asparagines-linked carbohydrates and possess phospholipase and subsequent lysophospholipase 
activity [32]. The distinction between PLB and LysoPLA can, rightly so, often be muddled since most 
PLBs possess lysophospholipase activity [33]. On the other hand, some PLB enzymes have been 
erroneously annotated. For example, a case in which a purified hamster heart cytosol enzyme clearly 
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displayed both sn-1 and sn-2 hydrolysis has been referred to as a PLA [34]. Also, the first so-called 
PLA1 to be purified, cloned, and crystallized was the outer-membrane phospholipase A (OMPLA) 
from E. coli and other bacteria [35–37], but it has been known for a long time that it can cleave at both 
positions sn-1 and sn-2 of diacyl- or lysoPLs and thus should be considered a phospholipase B [2,24]. 
LysoPLA (EC 3.1.1.5) detoxifies detergent-like lysoPL intermediates in PL metabolism by 
removing the remaining acyl chain from the lysoPL (Figure 1). This class of enzymes is also not well 
characterized. LysoPLA could also be important in the regulation of the amount of bioactive lysoPLs 
used in receptor-mediated or other signaling mechanisms [38]. Some LysoPLA can function equally 
well as either a LysoPLA1 or a LysoPLA2 [17]. Other LysoPLA can deacylate specific species of 
lysoPL, like those with AA esterfied to the sn-2 position, for example [18,39]. Such in vitro specificity 
has helped to fuel the theory that the AA cascade could be initiated by the combined actions of a PLA1 
and a LysoPLA2. 
 
1.3. The Phosphodiesterases: Phospholipase C and D 
 
PLC or PI-PLC (EC 3.1.4.11) is mostly known for catalyzing the cleavage of the phosphorylated 
membrane lipid PI to produce, for example, the intracellular second messengers sn-1,2-diacylglycerol [23] 
and inositol (1,4,5)-trisphosphate (Figure 2). The phosphoinositides are a critically important class of 
PLs which have been extensively researched, along with the mechanisms by which they are 
metabolized by PLC [40]. PLC-mediated phosphoinositide production is a key regulating component 
of ion channels and transporters,
 
and controllers of vesicular trafficking and the transport of
 
lipids 
between intracellular membranes [41]. Other types of PLC include a secreted form in bacteria that 
prefers PC (E.C. 3.1.4.3), and a GPI-PLC form found in various organisms that specifically recognises 
non-inositol-acylated glycosylphosphatidylinositol anchors. 
PLD (EC 3.1.4.4) hydrolyzes the sn-3 phosphodiester bond of mostly PC to generate a choline 
molecule and PA. PLD has also been studied in detail due to its link with the production of PA, an 
intracellular lipid messenger implicated in almost every conceivable aspect of intracellular membrane 
transport [42]. PLD is also a potential regulator of lyso-PA formation, whose biosynthetic formation is 
unclear, but could involve both PLD and PLA1 [43]. The mode of action and structural characteristics 
of the various isoforms of PLD are well characterized [42,44]. 
 
2. Classification of Phospholipase A1 
 
Over one hundred years ago accumulation of FFAs was observed upon incubation of pancreatic 
juice with phosphatidylcholine (PC), and the existence of enzymes responsible for the release of these 
acids was accordingly proposed. Snake venoms were also found to possess PL-hydrolyzing enzymes 
when in 1903 cobra venom was found to alter PC into products, which could cause red blood cell 
hemolysis. These products were later determined to be a PC molecule that was missing a FA, and they 
were thus termed lysophosphatidylcholine (lyso-PC). Only in the early 1960’s however was the 
positional specificity of FA cleavage of snake venom determined to be the sn-2 position of the glycerol 
backbone of PLs [44]. Early on, therefore, the study of PLA activity focused on PLA2 activity, as it has 
remained to this day. Nevertheless, phospholipases of type A were linked to those enzymes cleaving 
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FAs from PLs, and the designation A1 and A2 was employed to signify the acyl hydrolysis from either 
the sn-1 or sn-2 position of the glycerol moiety, respectively [45]. It wasn’t long before intracellular 
PLA activities were beginning to be discovered in numerous organisms and tissues, thus opening the 
way for the possibility that these enzymes were more than just digestive catalysts. 
PLA1 specifically hydrolyzes sn-1 acyl esters from PLs producing FFAs and lysoPLs (Figure 2). 
However, many PLA1 enzymes exhibit some, usually much lower, LysoPLA activity and neutral 
lipase activity (i.e., hydrolyzing diacylglycerol or triacylglycerol), yet still preferring the sn-1 cleavage 
site. Enzymes having high PLA1 relative to LysoPLA and neutral lipase activity are thus considered 
true PLA1 enzymes, and they can only be designated as such by empirical determination after some 
level of purification or, more preferably, by cloning and characterization of the recombinant enzyme. 
The vast amount of results from early studies involving the detection of PLA activity from crude tissue 
or subcellular fractions were flawed due to the inability to precisely determine what enzyme activities 
are present and how to differentiate particular enzyme activities. Competing and/or downstream 
enzyme activities on lipid substrates can mask the activity of the enzyme being tested. 
PLA1 enzymes have not been formally classified into groups, as have the other major 
phospholipases. The major obstacle is the lack of available sequence due to only a relatively small 
proportion of PLA1 enzymes having been cloned thus far (Table 1). The only invariable feature of 
PLA1 seems to be a lipase consensus motif in the peptide sequence, which follows the amino acid 
residue pattern [LIV]-{KG}-[LIVFY]-[LIVMST]-G-[HYWV]-S-{YAG}-G-[GSTAC], inside of 
which resides a common GXSXG motif, containing the catalytic serine of the active site, as part of a 
catalytic triad. 
PLA1 has been considered as a descendent of neutral lipases, and several PLA1 sequences show 
substantial sequence similarity to the well characterized pancreatic, hepatic, and endothelial  
lipases [43,46,47]. Other PLA1 sequences show no similarity to lipase sequences beyond their lipase 
consensus pattern, nor do they show similarity to other PLA1 sequences. Furthermore, eukaryotic 
lipases possess two domains whereas prokaryotic lipases only contain one, in which there is little if 
any conservation in sequence (compare alignments in [48–51]. 
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Table 1. The Phospholipase A1 Family 
1
. 
Classification Organism  Name 
2
 Location Cellular 
Localization 
~ Size (kDa) Substrate 
Specificity 
Catalytic 
Properties 
Reference 
Eukarya          
Animali: Bos taurus □ PA-PLA1 Testis, Brain Cytosolic 98 PA SXSXG catalytic 
serine3 
[52,53] 
 Mus musculus □ p125 Ubiquitous Cytosolic 111 nd4 GXSXG motif [54] 
 Homo sapiens □ KIAA0725p Ubiquitous Cytosolic 81 PA, PE GXSXG catalytic 
serine3 
[55] 
 Homo sapiens ● mPA-PLA1α Various tissues Secreted 58 PA Catalytic triad
5 [43,56] 
  ● mPA-PLA1β Reproductive tissues Mem-Ass 58 PA Catalytic triad
5 [43,56] 
   PLRP2      [50] 
 Rattus 
norvegicus 
● PS-PLA1 Platelets+various  Secreted 55 PS, lysoPS Catalytic triad
5 [46,48,57] 
 Dolichovespula 
maculate 
● Dol m I Venom sac Secreted 34 nd4 Catalytic triad5 [47] 
 Vespula spp. ● Ves v I Venom sac Secreted 34 nd4 Catalytic triad 5 [58–60] 
  ● Ves m I Venom sac Secreted 34 nd4 Catalytic triad 5 [58–60] 
 Caenorhabditis 
Elegans 
 IPLA-1  ER 87 PI Catalytic triad 5 [5] 
Plantae: Arabidopsis 
thaliana 
 DAD1 Anthers Chloroplast 45 PC6 GXSXG motif [61] 
   AtLCAT3 nd4 Microsomes 46 PC, PE, PA  SXSXG-catalytic 
triad3 
[62,63] 
Fungi: Aspergillus 
oryzae 
 AoPLA1 n/a
4 Secreted 36 nd4 GXSXG motif [64] 
 Thermomyces 
lanuginosus 
  n/a4 nd4  PC  [65] 
Protozoa: Trypanosoma 
brucei 
 TbPLA1 n/a
4 Cytosolic 34 PC GXSXG catalytic 
serine 3 
[49,66] 
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Table 1. Cont. 
Prokarya          
Bacteria: Serratia spp. ♦ PhlA n/a Secreted 34 nd4 GXSXG motif [67,68] 
  ♦ PlaA n/a Secreted 34 nd4 GXSXG motif [69] 
 Yersinia 
enterocolitica 
♦ YplA n/a Secreted 34 nd4 GXSXG motif [70] 
1 Only those PLA1 which have been cloned and reported in the literature have been included; 
2 Homologues are represented with the same symbol. 
Abbreviations are: PA-PLA1,phosphatidic acid-preferring PLA1; mPA-PLA1, membrane-associated phosphatidic acid-selective PLA1; PS-PLA1; 
phosphatidylserine-specific PLA1; DAD1, defective in anther dehiscence 1; AtLCAT3, Arabidopsis thaliana lecithin:cholesterol acyltransferases; SGR2, 
shoot gravitropism 2; PhlA, Serratia liquefaciens PLA1; PlaA, Serratia spp. MK1 PLA1; YplA, Yersinia enterocolitica; 
3 Empirically deduced; 4 nd = not 
determined, n/a = not applicable; 5 Deduced by similarity with its lipase homologues known to utilize a histidine, an aspartic Acid, and a GXSXG serine in a 
catalytic triad; 6. The only substrate tested. 
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3. Mammalian Phospholipase A1 
 
A large number of crude protein preparations from mammalian cell and tissue homogenates were 
enriched for PLA1 activity in the 1970’s and 1980’s, but many of these reports describe PLA1 activity 
of uncertain origin. A good example of this is the characterization of a ―phospholipase A1‖ from the 
plasma of rat liver that was found to hydrolyze triacylglycerols, diacylglycerols, and 
monoacylglycerols, in addition to PLs [71]. This ―phospholipase A1‖ was located on the surface of 
endothelial cells and was shown to play a role in high density lipoprotein metabolism, and two papers 
were published characterizing its ―phospholipase A1‖ activity. Interestingly, relatively recently a new 
member of the lipase family was cloned from endothelial cells and a recombinant form was shown to 
possess PLA1 activity [72]. Endothelial lipase most likely accounts for the majority of the PLA1 and 
lipase activities previously reported from enriched rat liver endothelial cell fractions. 
It us now generally accepted that mammals have six extracellular and three intracellular PLA1 
enzymes [50]. The extracellular PLA1s consist of phosphatidylserine (PS)-specific PLA1 (PS-PLA1), 
membrane-associated phosphatidic acid (PA)-selective PLA1s (mPA-PLA1α and mPA-PLA1β), these 
PLA1s may have physiological roles as they produce the lysophospholipids, lyso-PS and lyso-PA known 
to be lipid mediators with multiple biological functions. The other three extracellular enzymes are 
either involved in high-density-lipoprotein catabolism of triacylglycerol, hepatic lipase (HL) and 
endothelial lipase (EL), or digestion of dietary lipids, pancreatic lipase-related protein (PLRP)-2. These 
three enzymes belong to the lipase gene family showing triacylglycerol-hydrolyzing activity as well as 
PLA1 activity. The intracellular PLA1s, KIAA0725p and p125, are conserved in a wide range of 
organisms and have been implicated in vesicular transport. 
 
3.1. Bovine Brain PLA1  
 
One of the first phospholipases of the type A1 to be purified by column chromatography was from 
bovine brain [21]. The enzyme was isolated from the soluble fraction and eluted at a molecular mass 
of 365 kDa from a Sephacryl S-300HR column. Lipases are known for their interfacial activation 
properties, and the 365 kDa molecular weight obtained could reflect the enzyme’s molecular weight 
upon association with buffer detergent micelles, or it could represent the enzyme in tetramer form. 
Bovine brain PLA1 migrated as two bands of 112 kDa and 95 kDa by SDS-PAGE. The purified 
enzyme was shown to be resistant to metal chelators, PMSF, and DFP, but it was inactivated by ZnCl2 
and enhanced by Ca
2+
, Mg
2+
 and Sr
2+
. The enzyme exhibited broad substrate specificity in mixed 
micelles made with CHAPS, but the highest specific activity, 23.8 μmol/min/mg, was exhibited 
against PE(16:0/20:4), and LysoPLA1 activity was also observed. A subsequent study showed that PC 
and PI could also be catalyzed at a high rate by bovine brain PLA1 but only in the presence of other 
PLs like PS, PE, and PA [73]. This same group reported the first chromatographic purification of a 
LysoPLA2 that showed selectivity towards deacylating arachidonate from lyso-PC(−/20:4) [39]. In 
addition to its LysoPLA2 activity, this enzyme also showed PLA2 activity, but at a slower rate. Bovine 
brain LysoPLA2 was isolated from the soluble fraction and is an approximately 95 kDa polypeptide. 
Moreover, it became clear that prior sn-1 deacylation of PC(16:0/24:0) by bovine brain PLA1 greatly 
increased the rate of arachidonate deacylation by brain LysoPLA2. These results suggested that in 
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bovine brain AA might possibly be generated by sequential PLA1/LysoPLA2 action, yet this has never 
been shown in vivo. Even more, the physiological substrates for these two enzymes have never been 
determined so it is impossible to know whether arachidonoyl-substituted PC or PE are in fact 
hydrolyzed by these enzymes. Unfortunately, not knowing the in vivo physiological substrates is a 
recurring theme in PLA1 studies. It is also important to note that the genes encoding these two PLA 
activities have not been determined. 
 
3.2. Bovine Testis PA-PLA 
 
The phosphatidic acid-preferring phospholipase A1 (PA-PLA1) from bovine testis is well studied. 
The initial identification of PA-PLA1 was from Mono Q fractions of high-speed supernatants from 
bovine testis, and to a lesser extent in bovine brain [53]. The enzyme displayed preference for PA in 
TX-100 detergent mixed micelles, and it also displayed a relatively small amount of LysoPLA1 
activity. At the time of its identification, PA was just beginning to be recognized as a second 
messenger that could affect a number of cellular processes. The production and, particularly, the 
attenuation of signaling PA can be mediated by multiple phospholipases that regulate the timing, 
location, amount, and various molecular species of PA [74]. A 14,000-fold purification of native  
PA-PLA1 was achieved and evidence was provided that the enzyme was a homotetramer of  
110 kDa subunits [75]. When the enzyme was examined under the same conditions as the bovine brain 
PLA1 previously reported (i.e., 3–5 mM MgCl2) [21], the results showed that PE(16:0/24:0) became 
the preferred substrate. When MgCl2 was removed, PA-PLA1 preference for GPA was restored. It is 
thus possible that the bovine testis PA-PLA1 and the bovine brain PLA1 are one and the same enzyme. 
Further studies eventually led to the cloning of bovine testis PA-PLA1, which was encoded by an 
875 amino acid protein with a predicted molecular mass of 97.6 kDa [52]. A ~2000 fold increase in 
PA-PLA1 activity was observed when the protein was expressed in COS1 cells. A lipase-like 
consensus sequence was identified and the active site serine residue within a SXSXG motif was 
experimentally established as being essential for PA-PLA1 activity in the COS1 expression system. 
Apart from containing a lipase-like consensus motif, the PA-PLA1 sequence differed from other 
lipases and phospholipases. Homologues were identified in the genomes of Caenorhabditis elegans, 
yeast, Drosophila, and in human and mouse. A homologue involved in shoot gravitropism has also 
been identified in A. thaliana [63]. Splice variants were proposed to possibly exist after three cDNAs 
were found that contained a 123-base deletion, and it was put forth that if splice variants had different 
substrate specificities, then the seeming discrepancy between the bovine brain and testis substrate 
specificities may be explained in this manner. A complex array of conditions were created to examine 
properties of purified PA-PLA1 [75] using an interface composed of unilamellar lipid mixed micelles [76]. 
In the end, catalytic preference for PA(16:0/18:1) was reported to be observed when the unilamellar 
micelles contained (i) a low relative amount of PC; (ii) high relative amounts of PE, PS, and 
cholesterol; (iii) DAG; (iv) PE(18:0/20:4) instead of PE(16:0/18:1); and (v) 10 mol % PA  
per 100 mol % total phosphoglycerides. The study also showed that PA-PLA1 could bind to 
membranes composed of anionic phosphoglycerides and could be stabilized by these membranes in the 
presence of albumin.  
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Other experiments with PA-PLA1 provided information about the effects of phosphorylation and 
dephosphorylation on the behavior of the enzyme [77]. The first splice variant, PA-PLA1α, was 
recombinantly expressed in Sf9 cells and purified, though a homogeneous fraction of enzyme was not 
shown. The recombinant protein was shown by mass spectrometry to be phosphorylated by protein 
kinase CK2, with which it also formed complexes, and by extracellular signal-regulated kinase 2. They 
also showed that protein phosphatase 2A could dephosphorylate some of the phosphoryl 
modifications, which led them to raise the possibility that the native counterparts of these enzymes 
could coordinately regulate the phosphorylation state of PA-PLA1 in vivo. The physiological 
significance of PA-PLA1 still remains to debatably [50], because it is most highly expressed in testis it 
has been suggested that PA-PLA1 could be involved in PA signaling during spermiogenesis [74,76]. 
3.3. p125 and KIAA0725p 
 
Budding vesicles mediate transport of proteins between intracellular compartments. One of the 
components of ER to Golgi COPII-coated vesicles of the secretory pathway is the Sec23p-Sec24p 
complex. In a study, that attempted to affinity isolate and identify new Sec23p-interacting proteins a 
novel protein, p125 (111 kDa), was identified. The predicted peptide sequence of p125 was 
homologous to bovine PA-PLA1 [54]. In addition, the N-terminal region of p125 contains a proline-rich 
region that was shown to be the functional region of the enzyme in its association with Sec23p. 
Detection of low levels of recombinant p125 expression showed co-localization with β-COP and 
ERGIC53, an ER-Golgi intermediate compartment marker. In contrast, detection of high levels of 
p125 over-expression revealed p125 dispersed throughout the cells, not only in membranes, but also in 
the cytosol, causing disorganization of the ER-Golgi intermediate compartments. ERGIC-53 also 
showed a dispersed staining pattern in these cells, and a second type of staining showed that the Golgi 
itself was dispersed. p125 was also shown to co-localize with p115 and GM130 proteins [78], both of 
which play a role in vesicle tethering to Golgi membranes [79]. Depletion of p125 by RNAi suggested 
that p125 is needed for the proper organization and distribution of ER exit sites; however, p125-depleted 
cells maintained regular rates of protein transport from the ER [80]. Despite these detailed studies, no 
examination of stereo-specific enzyme activity was undertaken, so p125 may indeed not even  
be a PLA1. 
However, another protein, KIAA0725p, has also been identified as a homologue of both bovine 
PA-PLA1 and p125 [55]. KIAA0725p is ubiquitously expressed in mammalian cells and is 
predominantly localized in the cytoplasm. Consistent with its bovine PA-PLA1 homologue, 
KIAA0725p preferentially cleaves the sn-1 ester linkage of PA; however, in the absence of detergent it 
also hydrolyzed PE. PA specificity was determined using homogenates of KIAA0725p-expressing 
cells, and homogenates with the GXSXG seryl residue mutated to alanine showed no PLA1 activity. 
Like p125, results showed that over-expression of KIAA0725p in cultured cells provoked dispersion of 
ERGIC53 and β-COP; but, unlike p125, over-expression also caused dispersion of p115 and GM130. This 
morphological phenotype was not due to PLA1 activity because over-expression of the lipase-inactive 
mutant caused the same phenotype. However, over-expression of KIAA0725p, but not its lipase-inactive 
mutant, also caused aggregation of the ER, which was thus determined to be dependent on PLA1 
activity. The authors proposed that KIAA0725p may promote fusion of ER membranes by changing 
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cone-shaped PA to inverted-cone shaped lyso-PA, which has been suggested to promote fusion pore 
formation, the last step of membrane fusion [81]. Recently it has been shown that the isoform iPLA(1) 
g is a novel membrane transport factor that mediates a membrane transport pathway between the ER 
and the Golgi that is distinct from the previously characterized COPI- and Rab6-dependent pathways [82]. 
 
3.4. PS-PLA1 
 
A novel PLA1 secreted from rat platelets was the first PLA1 discovered which preferentially cleaves 
FAs from PS [46]. The predicted peptide sequence from the cloned cDNA of PS-PLA1 was found to 
show significant sequence homology to hepatic lipase, lipoprotein lipase, pancreatic lipase, and 
endothelial lipase, but the enzyme does not possess appreciable neutral lipase activity. The  
enzyme was partially purified by sequential column chromatography from the culture medium of 
thrombin-activated platelets, and from medium of insect Sf9 cells expressing recombinant PS-PLA1 in 
a baculovirus system. The resulting enzyme was shown to be a 50–55 kDa protein that was equally 
active towards PS and lyso-PS. PS-PLA1 is also believed to be a glycoprotein. Due to its sequence 
similarity with lipases, the primary PS-PLA1 peptide sequence reveals that is has a β-9 loop  
and a lid domain; but PS-PLA1 has shorter versions of each [46], which could explain why 
diisopropylphosphofluoridate (DFP) inhibits this enzyme, if the truncated lid domain ineffectively 
covers the active site serine. A subsequent study revealed that PS-PLA1 might be the synthetic route in 
the production of bioactive lyso-PS since it was shown that it has the ability to efficiently stimulate 
histamine release from rat peritoneal mast cells, especially when in the presence of apoptotic Jurkat 
cells [83]. In this system, 2-acyl-1-lysoPS was released from apoptotic cells exposed to PS-PLA1 and it 
was proposed that PS-PLA1 may play an in vivo role in hydrolyzing PS exposed on plasma membranes 
of apoptotic, dead, and cytokine-stimulated cells, as a means to transduce mast cell activation mediated 
by 2-acyl-1-lysoPS. PS-PLA1ΔC, a splice variant of the human version of PS-PLA1, shows poor 
catalytic activity towards PS and the other diacylPLs but is able to deacylate lyso-PS effectively and is 
therefore a LysoPLA [84]. PS-PLA1ΔC possesses a truncated C-terminal region; therefore peptides on 
the complete C-terminal domain of PS-PLA1 are thought to play a role in substrate recognition. In a 
very recent study PS-PLA1 expression in human THP-1-derived macrophages, responsible for the 
immune responses to allograft rejection, are activated via TLR4. This activation can be inhibited by 
corticosteroids, which are used at high dosages to suppress chronic allograft rejection [57]. 
 
3.5. mPA-PLA1 
 
A sequence similarity search of the PS-PLA1 detected another PLA1 enzyme which was 
homologous to neutral lipases, that of membrane-associated phosphatidic acid-selective 
phospholipase A1 alpha and beta (mPA-PLA1α/β) [43,56]. Both recombinant forms show PA-specific 
substrate specificity. Attempts to purify the recombinant membrane proteins from Sf9 cells failed but 
medium from mPA-PLA1α-expressing cells was shown to activate a lyso-PA receptor family member, 
LPA3/EDG7. Medium from cells expressing an active site serine mutant failed to induce a receptor 
response. These results indicated that cells expressing recombinant mPA-PLA1α were able to produce 
and release bioactive lyso-PA. When expressed in HeLa cells mPA-PLA1α was recovered from the 
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cell supernatant whereas mPA-PLA1β was still membrane associated [56]. A set of elegant 
experiments also showed that mPA-PLA1α/β acted after and in concert with both endogenous and 
exogenous PLD to form lyso-PA. This report thus suggests a possible in vivo metabolic pathway for 
lyso-PA production involving the sequential action of a PLD and mPA-PLA1α/β. Thus, both  
PS-PLA1 and mPA-PLA1α/β thus have evolved from lipases to specialize in producing bioactive  
lyso-PL mediators [5]. 
 
3.6. Guinea-Pig Heart Microsomal PLA1 
 
It has been reported that microsomes from guinea-pig heart possess PLA1 activity on PE and PC, 
and that sn-1 cleavage could be influenced by the sn-2 FA since more efficient hydrolysis was 
observed when the sn-2 FA was polyunsaturated [85]. The enzyme(s) responsible for PLA1 activity 
from guinea-pig heart microsomes have not been identified and purified to any extent other than into 
subcellular fractions, but a few studies are worth mentioning since they are devoted to possible 
regulatory mechanisms of PLA1 activity in this tissue, and very few other studies exist that begin to 
explain how some PLA1 activity could be controlled. No PLA1-activating agonists are known, so a 
possibility that PLA1 could be receptor activated by G-proteins was investigated by measuring the 
response of PLA1 activity towards guanine nucleotides, which can activate G-proteins. PLA1 activity 
towards PC(16:0/18:2) was partially inhibited by guanosine 5'-[γ-thio]triphosphate (GTP[S]), but not by 
GTP, guanosine 5'-[γ-thio]diphosphate (GDP[S]), GDP, ATP or adenine 5'-[γ-thio]diphosphate 
(ATP[S]) [86]. On the other hand, PLA1 activity on PE(16:0/18:2) was stimulated by GTP[S] but not 
GDP[S] or ATP[S] [86]. PE(16:0/18:2) hydrolysis by guinea-pig heart microsomes was also shown to 
be stimulated 40–60% by isoprenaline. It has still yet to be shown in vivo if PLA1 activity in guinea-pig 
heart microsomes is activated by the binding of isoprenaline to adrenergic receptors and mediated via 
activation of G-proteins. Without either the purification or cloning of the enzymes responsible for this 
activity in guinea-pig heart microsomes, it is unlikely that any resolution of the issue will be made. It 
is worth recalling, however, that a ubiquitously expressed mammalian PA-PLA1 homologue, p125, is 
localized to the ER and interacts with Sec23p, which acts as a GTPase-activating protein that plays a 
role in uncoating budding vesicles [87]. Whether these PLA1 activities are due to the same or different 
enzymes is unknown, but it does stress the importance of how substrate specificity is analyzed in vitro, 
and the caution with which to interpret such data. To confuse the situation even further, guinea-pig 
heart microsomes were also shown to possess a LysoPLA2 that could hydrolyze lyso-PC(−/18:2 or 
20:4) more efficiently than lyso-PC(−/18:1 or 16:0) [18].This result lent some support to the standing 
possibility that arachidonic and linoleic acids could be released by LysoPLA2 acting in concert  
with a PLA1.  
 
4. Other PLA1  
 
PLA1 is a ubiquitous enzyme found in nearly every cell where it has been sought, and this includes 
metazoan and protozoan parasites, and snake venoms. 
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4.1. Caenorhabditis elegans PLA1 
 
The Caenorhabditis elegans, IPLA-1 and ACL-10 have phospholipase A1 and acyltransferase 
activity respectively,
 
both of which recognize the sn-1 position of their PI substrate [88]. The PI  
sn-1 fatty acid remodeling by sequential deacylation and reacylation, which resulted in stearic  
acid as the major fatty acid at the sn-1 position, has been proposed to be crucial for asymmetric  
division [5]. 
 
4.2. Venom PLA1 
 
The cDNA of one allergen component of Dolichovespula maculate (white-faced hornet) venom has 
been cloned and shown to encode a PLA1 (Dol m I) with weak lipase activity [47]. In fact, at the time 
of the study, the derived peptide sequence of Dol m I had no homology to other PLA1 genes because it 
was similar to mammalian lipases. Now, not only is Dol m I 40% identical to pancreatic, hepatic, 
lipoprotein, and endothelial lipase, but it also shows homology with PS-PLA1 [46] and mPA-PLA1 [43]. 
Characterization of the 34–37 kDa enzyme has not been undertaken presumably due to a priority 
interest in understanding its immunochemical properties as it relates to its contribution to allergenicity. 
Along these same lines, two homologues of Dol m I have been cloned from Vespula spp. (yellow 
jacket) (Ves v I and Ves m I) which show 67% sequence identity with the white-faced hornet  
PLA1 [58,59], and recent success in recombinant expression of PLA1 (Ves v I) from the yellow jacket 
will allow a more detailed understanding of the molecular and allergological mechanisms of insect 
venoms, providing a valuable tool for diagnostic and therapeutic approaches in hymenoptera venom 
allergy [60].  
 
4.3. Trypanosoma brucei PLA1  
 
The PLA1/LysoPLA theorized coordinated route towards the release of unsaturated FAs, (e.g., 
arachidonic acid (AA)), has been supported by in vitro studies using homogenates from the kinetoplastid 
protozoan parasite Trypanosoma brucei, the infective agent of African sleeping sickness [23]. These 
studies observed robust and optimal activity at pH 6.0–8.5 and a requirement of sn-1 acyl cleavage 
prior to the release of AA from sn-1-palmitoyl-sn-2-arachidonoyl-sn-glycero-3-phosphatidylcholine 
[PC (16:0/20:4)] [89–91]. The liberated unsaturated FAs such as AA from lipids in T. brucei have 
been implicated in regulating calcium mobilization [92,93], and as a precursor for prostaglandin 
biosynthesis [94]. 
Two recent detailed studies describe the cloning and characterization of the cytosolic T. brucei 
PLA1. TbPLA1 is unique from other eukaryotic PLA1 because it is phylogenetically related to bacterial 
secreted PLA1 [49,66]. TbPLA1 was most likely acquired by a prokaryotic-to-eukaryotic horizontal 
gene transfer event of a PLA1 from Sodalis glossinidius, a bacterial endosymbiont of the insect vector 
of the protozoan parasite, the tsetse fly. These studies employed both in vitro and in vivo analytical 
techniques to establish that PC is the preferred substrate. The TbPLA1 homozygous null mutants 
constitute the only PLA1 double knockouts from any organism and helped to established that the  
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enzyme functions in vivo to synthesize lyso-PC metabolites containing long-chain mostly 
polyunsaturated and highly unsaturated fatty acids. 
 
4.4. Trypanosoma cruzi PLA1  
 
One report described the existence of PLA1 activity in Trypanosoma cruzi, the etiologic agent of 
Chagas disease [95]. When trypomastigote and amastigote suspensions were radiolabeled with oleic 
acid and lysed, the radiolabeled PC content decreased over time. In addition, when PC(16:0/18:1) was 
incubated with epimastigote homogenates at pH 4.7, lyso-PC(−/18:1) was produced, suggesting sn-1 
hydrolytic specificity. T. cruzi PLA1 was partially purified (1900-fold by specific activity) from 
epimastigote homogenate supernatants and a protein band of 38 kDa could be seen by SDS-PAGE, 
and size exclusion chromatography suggested PLA1 activity eluted with an apparent molecular mass of 
40 kDa. T. cruzi PLA1 seems to be a glycoprotein due to its binding to ConA-Sepharose, possesses no 
divalent cation requirements, and is released from the cell by digitonin together with lysosomal 
markers. The physiological role played by lysosomal T. cruzi PLA1 has not been determined, though 
the authors suggest that the FA and lyso-PL products could have a possible role in pathogenesis of  
the disease. 
 
5. Plant Phospholipase A1 
 
Evidence for the existence of PLA1 in plant cells wasn’t forthcoming until relatively recently when 
the tonoplasts of Acer pseudoplatanus were shown to be able to hydrolyze sn-2-radiolabeled PC into 
radiolabeled PA and radiolabeled lyso-PC, revealing PLD and PLA1 activities, respectively [96]. Since 
then, only a few genes encoding PLA1 have been discovered. 
 
5.1. DAD1 
 
Among the plant hormones jasmonic acid is considered a multifunctional growth and stress  
regulator [97], and it is structurally similar to ―animal‖ eicosanoids. Jasmonic acid is an oxylipin 
signaling molecule and a derivative of linolenic acid (C18:3). Jasmonate has been shown to regulate or 
co-regulate a variety of processes in plants, such as responses to biotic and abiotic stresses, tendril 
coiling, fruit ripening, and the developmental maturation of stamens and pollen in Arabidopsis. The 
enzymes involved in the jasmonic acid biosynthetic pathway have been elucidated, but the last one 
discovered, a phospholipase A1 called Defective in Anther Dehiscence 1 (DAD1), was one of the most 
important because it is the enzyme responsible for the initial release of C18:3 from cellular lipids [61]. 
Starting from an Arabidopsis thaliana DAD1 mutant, the WT DAD1 gene was isolated and found to 
encode a chloroplastic 45 kDa PLA1 lipolytic enzyme. A rescued phenotype was attained by either 
complementing the mutant with WT DAD1 or after supplying exogenous jasmonic acid. The DAD1 
protein sequence showed some apparent similarities with fungal lipases, it possessed a consensus 
GHSLG motif, and eleven homologous proteins were identified in Arabidopsis alone. A maltose 
binding-DAD1 fusion protein lacking 72 amino acid residues (an N-terminal transit peptide) was 
recombinantly expressed and used to examine lipase activity. PC was the only PL tested, and the 
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activity on it was more than 80% greater than on TAG, which suggested that the C18:3 precursor for 
jasmonic acid biosynthesis is stored in cellular PLs. DAD1 is thought to be of prime importance for 
the regulation of jasmonic acid levels. A PLA1 from Capsicum annuum (hot pepper) showed a 
considerable degree of overall sequence identity to Arabidopsis [98]. 
 
5.2. AtLCAT3 
 
In a search for A. thaliana sterol acyltransferases, one of the four enzymes found to be homologous 
to lecithin (PC): Cholesterol acyltransferases was determined to possess PLA1 activity [62,63]. 
AtLCAT3 (Arabidopsis thaliana lecithin:cholesterol acyltransferase 3) heterologous expression in 
yeast resulted in the PC, PS, and PE content to be half as much as those species in control yeast, while 
lyso-PC, lyso-PE and FFA were strongly increased. There was also a higher TAG content in the cells 
expressing AtLCAT3. AtLCAT3 fractionated with yeast microsomes, which subsequently shown to be 
able to hydrolyze various PL species, including lyso-PC and PA. However, neither acyltransferase 
activity nor TAG activity was observed with yeast microsomes expressing the enzyme. The analogous 
serine, histidine and aspartic acid residues that are part of the conserved catalytic triad of Homo 
sapiens LCAT were shown to be essential for activity of AtLCAT3. The physiological role of 
AtLCAT3 is as yet unknown. 
 
6. Bacterial PLA1 
 
The discovery of prokaryotic versions of PLA1 enzymes have up to now been confined to only one 
subclass of bacteria, the proteobacteria [68]. PLA1 from Serratia liquefaciens (PhlA) was identified as 
one of a number of proteins that are excreted to the outside environment. The impetus for studying 
PhlA was to use S. liquefaciens as a model organism to study the genetic basis for secreting proteins 
across both the periplasmic and outer membranes in gram-negative bacteria. As a result, very little 
biochemical information regarding PhlA is known. In fact, phospholipase activities of this enzyme 
were only examined against egg yolk PC imbedded in agar plates in which transparent halos were 
observed after the addition of cells expressing the enzymes. The presence of a halo around the colony 
indicated secreted phospholipase A activity, but did not discern between sn-1 and sn-2 specificity. 
PhlA encodes a 34 kDa polypeptide that has an N-terminal signal peptide. Immediately downstream 
from the PhlA gene is PhlB, which encodes a protein of 24 kDa. 
The bacterial exoenzyme PhlA was shown to have growth-phase-dependent expression and 
secretion, where a very low rate of PhlA production was measured during exponential growth, and a 
burst of expression and secretion was observed during stationary phase. In another report it was shown 
that PhlA expression is regulated at the level of transcription initiation, and they present sequence data 
of two dual promoters upstream of PhlA that regulate expression differentially during anaerobic 
conditions or growth-phase [99]. A subsequent study revealed that PhlA secreted from in E. coli was 
dependent on an intact flhD gene, the regulator of the flagellar/chomotaxis opero [67,100]. Mutant flhD 
strains of E. coli do not secrete recombinant PhlA, which accumulates inside the cell. Interestingly, the 
PLA1 activity of accumulated PhlA is attenuated by PhlB, which forms an enzymatically inactive 
complex with PhlA, thus neutralizing possibly lethal intracellular phospholipase activity. 
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A homologue (74% identity) of PhlA was identified in Yersinia enterocolitica (YplA) [70]. The 
YplA sequence revealed two ORFs in tandem like that of the PhlA and PhlB, but the YplB accessory 
protein was less similar to PhlB. Again, the phospholipase A activity was confirmed by testing on 
lecithin plates only. An insertion mutant of YplA was created and used in a mouse model to show that 
secreted YplA could play a role as a virulence factor in the pathogenesis of infection with  
Y. enterocolitica. Neither PhlA nor YplA are homologous to bacterial lipases. 
 
7. PLA1 in Biotechnology 
 
LysoPLs are commonly used as surfactants in food technology and cosmetics [101], and as 
components of liposomes used in drug delivery [102]. Lyso-PLs are currently produced commercially 
via their chemical synthesis [103] or via the action of extracts from porcine pancreas, which contains a 
PLA2. Viable alternative processes produce lyso-PLs enzymatically and with greater efficiency are 
being investigated, recently reviewed in [104]. 
Phospholipases are useful tools in analytical PL analysis. Though there are a number of sources of 
PLA2 commercially available at various levels of purification, no PLA1 in any form is commercially 
available, mainly due to the difficulty in producing and purifying the enzyme, especially on an 
industrial scale. The ciliated protozoan Tetrahymena thermophila has been studied as a potential 
natural source for PLA1 [105], which is secreted from this organism. However, high levels of PLA1 are 
undoubtedly best obtained through recombinant expression techniques. Since purified PLA1 is 
expected to have broad industrial applications, a number of PLA1 genes from a variety of 
microorganisms have been cloned and attempted to be expressed and purified to fulfill this need, but 
they have not been characterized.  
Serratia spp. MK1 PLA1 (PlaA), a homologue of PhlA and YplA, has been isolated from Serratia 
spp. MK1 in Korean soil and cloned and expressed in E. coli [69]. Though the enzyme is secreted 
naturally, over-expression resulted in accumulation of recombinant enzyme inside the cell, and  
co-expression of its accessory protein, PlaS, was essential for cell viability and high expression levels. 
The histidine affinity tag on the recombinant protein was used in a one-step purification of the enzyme, 
which yielded under the best conditions 2.2 mg/L, the purity level was neither reported nor shown. 
Also, PLA1 in organisms adapted to lower temperatures have recently been found [106]. 
The genomic DNA and cDNA encoding a 269 amino acid PLA1 protein from Aspergillus oryzae 
have also been cloned [64]. The peptide sequence of the PLA1 showed 47% identity with that of 
mono- and diacylglycerol lipase from another fungus, Penicillium camembertii. A. oryzae PLA1 is a 
secretary enzyme and it was recombinantly expressed in the yeast Saccharomyces cerevisiae and 
purified from the extracellular broth at a level of 3.9 mg/L. Under a complex array of conditions, this 
expression was optimized to produce approximately 2 g/L on an industrial scale fermentor [107]. 
However, the enzyme was only partially purified from the culture broth by ion exchange 
chromatography and the yield was calculated based on its specific activity. Recently a PLA1 from 
Thermomyces lanuginosus expressed in Aspergillus has been commercialized as a lectinase [65].  
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8. Perspective 
 
Phospholipases A1 are enzymes that hydrolyze phospholipids at the sn-1 fatty acids from 
phospholipids and produces 2-acyl-lysophospholipids. This PLA1 activity is conserved in a wide range 
of organisms, but is carried out by a diverse range of enzymes. 
Despite PLA1 activities being detected in many tissues and cell lines, only a limited number of 
PLAs have been cloned and their activity and substrates identified and characterized, and even fewer 
have been studied that their function is known.  
PLA1s have been shown to have a diverse range of cellular functions including, digestive enzymes, 
central roles in membrane maintenance and remodeling via the Lands cycle of important phospholipids 
or glycolipids such as glycosylphosphatidylinositols. It is now emerging that they also regulate and 
facilitate the production of various lysophospholipid mediators, such as lysophosphatidylserine and 
lysophosphatidic acid, which in turn have multiple important biological functions. 
Thus, phospholipases A1 are an emerging class of enzyme that play important roles in the cellular 
functions including those of various diseases and pathogens that affect human health. 
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